We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YALA
3251
Yalla Group
YALA
$832M
| $115K | ﹤0.01% |
+26,291
| New | +$105K |
|
3252
Adicet Bio
ACET
$74.7M
| $114K | ﹤0.01% |
2,939
-37
| -1% | -$3.27K |
|
3253
iShares MSCI Netherlands ETF
EWN
$637M
| $114K | ﹤0.01% |
+2,638
| New | +$112K |
|
3254
Pulse Biosciences
PLSE
$2.94B
| $113K | ﹤0.01% |
+15,785
| New | +$101K |
|
|
LBPH
3255
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $113K | ﹤0.01% |
+15,382
| New | +$116K |
|
|
OMGA
3256
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $113K | ﹤0.01% |
+20,141
| New | +$158K |
|
3257
Ascendis Pharma A/S
ASND
$16.8B
| $112K | ﹤0.01% |
+1,258
| New | +$109K |
|
3258
Bakkt Inc
BKKT
$337M
| $112K | ﹤0.01% |
3,651
+3
| +0.1% | +$105 |
|
3259
Samsara
IOT
$23.8B
| $112K | ﹤0.01% |
+4,044
| New | +$89.6K |
|
3260
374Water
SCWO
$37.6M
| $112K | ﹤0.01% |
+4,676
| New | +$149K |
|
3261
XPeng
XPEV
$11.6B
| $111K | ﹤0.01% |
+8,295
| New | +$81.7K |
|
3262
TeraWulf
WULF
$8.52B
| $111K | ﹤0.01% |
63,293
-1,876
| -3% | -$2.86K |
|
3263
J. Jill
JILL
$283M
| $111K | ﹤0.01% |
+5,167
| New | +$119K |
|
|
SMLR
3264
DELISTED
Semler Scientific
SMLR
| $110K | ﹤0.01% |
+4,209
| New | +$111K |
|
|
JOYY
3265
JOYY Inc
JOYY
$3.75B
| $110K | ﹤0.01% |
+3,569
| New | +$105K |
|
3266
LanzaTech
LNZA
$69.8M
| $110K | ﹤0.01% |
+160
| New | +$63.2K |
|
3267
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $109K | ﹤0.01% |
+2,430
| New | +$104K |
|
3268
System1
SST
$17.5M
| $109K | ﹤0.01% |
+2,428
| New | +$91.9K |
|
3269
iShares MSCI Turkey ETF
TUR
$213M
| $109K | ﹤0.01% |
+3,860
| New | +$119K |
|
|
GOCO
3270
DELISTED
GoHealth
GOCO
| $109K | ﹤0.01% |
+5,530
| New | +$86.8K |
|
|
PPTA
3271
Perpetua Resources
PPTA
$3.09B
| $109K | ﹤0.01% |
+29,624
| New | +$136K |
|
3272
Nkarta
NKTX
$172M
| $108K | ﹤0.01% |
49,528
-1,708
| -3% | -$7.51K |
|
3273
Nuvectis Pharma
NVCT
$617M
| $108K | ﹤0.01% |
+6,778
| New | +$108K |
|
3274
Townsquare Media
TSQ
$118M
| $108K | ﹤0.01% |
+9,076
| New | +$88.5K |
|
3275
Cue Biopharma
CUE
$114M
| $107K | ﹤0.01% |
+980
| New | +$115K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.